Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma. (Record no. 24660281)

MARC details
000 -LEADER
fixed length control field 01575 a2200481 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517020636.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201511s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1476-5551
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/leu.2015.54
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Shah, N
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20151120
245 00 - TITLE STATEMENT
Title Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Leukemia
Date of publication, distribution, etc. Sep 2015
300 ## - PHYSICAL DESCRIPTION
Extent 1945-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hematopoietic Stem Cell Transplantation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lenalidomide
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melphalan
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Myeloma
General subdivision mortality
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thalidomide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Transplantation, Autologous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thall, P F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fox, P S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bashir, Q
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shah, J J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parmar, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lin, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kebriaei, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nieto, Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Popat, U R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hosing, C M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cornelison, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shpall, E J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Orlowski, R Z
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Champlin, R E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Qazilbash, M H
773 0# - HOST ITEM ENTRY
Title Leukemia
Related parts vol. 29
-- no. 9
-- p. 1945-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/leu.2015.54">https://doi.org/10.1038/leu.2015.54</a>
Public note Available from publisher's website

No items available.